Lataa...
Molecular portraits and trastuzumab responsiveness of estrogen receptor-positive, progesterone receptor-positive, and HER2-positive breast cancer
Background: Estrogen receptor-positive, progesterone receptor-positive, and HER2-positive breast cancers (triple-positive breast cancers, TPBCs) account for 5% to 10% of all breast cancers. The clinical and molecular features of TPBCs remain elusive. In this study, we aim to analyze the multiomics l...
Tallennettuna:
| Julkaisussa: | Theranostics |
|---|---|
| Päätekijät: | , , , , , , |
| Aineistotyyppi: | Artigo |
| Kieli: | Inglês |
| Julkaistu: |
Ivyspring International Publisher
2019
|
| Aiheet: | |
| Linkit: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6691389/ https://ncbi.nlm.nih.gov/pubmed/31410192 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.7150/thno.35730 |
| Tagit: |
Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!
|